Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Oral and Maxillofacial Surgery · Oral Leukoplakia

Can Leukoplakia Without Dysplasia Become Oral Cancer?

At a Glance

Leukoplakia with no dysplasia has a lower oral cancer risk than leukoplakia with dysplasia, but the risk is not zero. Studies estimate about 2.2% over five years and roughly 4.9% to 5.1% over 10 years or longer, so personalized follow-up remains important.

If your leukoplakia biopsy shows “no dysplasia,” it means no precancerous cellular changes were seen in the small piece of tissue that was sampled. It is natural to feel relieved, and this result genuinely lowers your risk compared to someone who does have dysplasia. However, it does not mean your future risk of developing oral cancer is completely zero [1][2]. Because leukoplakia can change over time and biopsies only sample a fraction of the tissue, ongoing, individualized monitoring remains an important part of your care.

The Numbers in Context

Current studies show that a small percentage of non-dysplastic leukoplakia lesions may eventually progress to oral cancer. The estimates vary because researchers study different patient populations and follow them for varying lengths of time:

  • Short-to-Medium Term: A large health system study found a 2.2% cumulative risk of a patient developing oral cancer over 5 years when their biopsied leukoplakia showed no dysplasia [2].
  • Long Term: Other studies tracking patients for 10 years or more have found that between 4.9% and 5.1% of patients eventually developed cancer [1][3].

You may also hear a statistic that nearly 40% of oral cancers developing from biopsied leukoplakias come from lesions that originally showed no dysplasia [2]. This does not mean you have a 40% chance of developing cancer. Rather, because non-dysplastic leukoplakia is so much more common than the dysplastic kind, the large number of non-dysplastic cases means a significant portion of all cancers still emerge from this group over time. These numbers are broad study averages, not a personal prediction of what will happen to you.

Why Does a Low Risk Persist?

There are several reasons why a reassuring biopsy today doesn’t guarantee you will never develop cancer:

  • Sampling Error: An incisional biopsy removes only a tiny piece of the white patch. Leukoplakia can be heterogeneous, meaning different areas of the same patch can have different types of cells. It is possible that the most abnormal cells were simply not located in the exact spot that was biopsied [4].
  • Microscopic Changes Over Time: The cells in your mouth can continue to change. A patch that is benign today can evolve and develop dysplasia or cancer months or years later [5].
  • Field Cancerization: This concept means that the broader area of tissue inside your mouth may have an increased genetic susceptibility to abnormal changes, even if the specific spot tested looks completely normal [6]. This is why cancer can sometimes develop in neighboring tissue or after a lesion has been removed.
  • Subtle Cell Changes: Sometimes, a very subtle type of abnormal cell growth called differentiated dysplasia can be difficult to recognize under a microscope. While rare, this can lead to an initial report of “no dysplasia” even if the lesion carries a higher risk [7][8]. Do not assume your report missed this, but a specialist review might be considered if your lesion looks highly suspicious despite a clear pathology report.

Modifiable Risk Factors

While you cannot control the cellular genetics in your mouth, addressing lifestyle factors is an important part of your care. Tobacco use, for example, has been strongly associated with the presence of carcinoma within leukoplakia [9]. Stopping the use of cigarettes, smokeless tobacco, and areca/betel nut, as well as limiting alcohol consumption, is generally advised to reduce overall irritation and cancer risk. However, it is important to know that while quitting lowers your overall risk, even non-smokers can experience malignant transformation, so everyone with a history of leukoplakia needs ongoing monitoring [10].

High-Risk Features of the Lesion

Even without dysplasia, certain physical features of your leukoplakia can increase the likelihood of future problems:

  • Appearance: The lesion is non-homogeneous (mixed red and white, speckled, pebbly, or ulcerated) rather than a flat, uniform white patch [10][11].
  • Location: The patch is located on the floor of the mouth or the lateral (side) of the tongue [12][13].
  • Size: The lesion is large. Studies often use a threshold of 200 square millimeters (a patch roughly 1.5 centimeters, or just over half an inch, across) to indicate higher concern [12].
  • Behavior: The patch persists, continues to grow, changes in texture, or comes back after being surgically removed [14][5].

If you have multiple persistent, spreading, or recurring lesions, a specialist may evaluate you for an uncommon, distinct condition called Proliferative Verrucous Leukoplakia (PVL). PVL carries a much higher risk of oral cancer (studies estimate 44% to 48% over the long term) and requires very close, specialized management [15][16]. Keep in mind that most people with a single non-dysplastic lesion do not have PVL.

Treatment and Ongoing Follow-Up

Because leukoplakia can evolve [5], ongoing follow-up is recommended. The schedule and approach should be tailored to you. Depending on the size, location, and appearance of your lesion, your doctor may recommend continued observation or complete surgical removal. Note that even if a lesion is completely removed, your risk in that area and surrounding tissues is not entirely eliminated.

If the clinical appearance of your leukoplakia looks highly suspicious but the biopsy comes back clear (a situation called clinicopathologic discordance), your doctor may recommend a repeat biopsy [9].

When to Call Your Doctor: Do not wait for your next scheduled appointment if you notice rapid growth, a new red or mixed red-white area, persistent ulceration, bleeding, increasing pain, firmness, numbness, or difficulty chewing or swallowing. These changes warrant prompt evaluation.

Common questions in this guide

Does no dysplasia mean my leukoplakia cannot become oral cancer?
No. A biopsy showing no dysplasia means no precancerous cell changes were seen in the sampled tissue, which is reassuring, but it does not make oral cancer risk zero. The patch can change over time and a biopsy samples only part of it, so follow-up remains important.
How likely is oral cancer after a leukoplakia biopsy shows no dysplasia?
Studies estimate about a 2.2% cumulative risk over five years. Studies following people for 10 years or longer have reported about 4.9% to 5.1% developing oral cancer. These are averages across groups, not a personal prediction; your risk depends on lesion features, exposures, and follow-up.
Why can a biopsy be reassuring if a leukoplakia later changes?
A biopsy that removes only part of a white patch samples a small area, and different parts may contain different cells. Cells can also change after the biopsy, and subtle abnormal patterns can be hard to recognize. If the patch looks concerning despite a clear result, a clinician may recommend a repeat biopsy or specialist review.
What features make leukoplakia without dysplasia more concerning?
Concern is higher when the patch is mixed red and white, speckled, pebbly, or ulcerated rather than evenly white. A lesion on the floor of the mouth or side of the tongue, a large lesion, or one that persists, grows, or returns after removal also warrants closer attention. Multiple lesions may prompt evaluation for proliferative verrucous leukoplakia, a separate condition with a much higher long-term cancer risk.
Should leukoplakia with no dysplasia be removed or monitored?
Either continued observation or complete surgical removal may be appropriate, depending on the patch’s size, location, appearance, and behavior. Surgery can remove the visible lesion, but it does not eliminate risk in nearby tissue or guarantee that the problem will not return. Discuss the benefits, risks, and follow-up plan with your oral healthcare clinician.
What changes should prompt an earlier appointment for leukoplakia?
Contact your clinician promptly for rapid growth, a new red or mixed red-and-white area, persistent ulceration, bleeding, increasing pain, firmness, numbness, or difficulty chewing or swallowing. Do not wait for the next routine visit if these changes appear. They do not prove cancer, but they need timely evaluation.
Can stopping tobacco lower my risk if my leukoplakia has no dysplasia?
Stopping cigarettes and smokeless tobacco, avoiding areca or betel nut, and limiting alcohol can reduce overall irritation and oral cancer risk. However, oral cancer can still develop in people who do not use tobacco, so lifestyle changes do not replace surveillance. Ask your clinician about cessation support if you want help making these changes.

Get notified when new evidence is published on oral mucosa leukoplakia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Malignant Transformation Rate of Non-reactive Oral Hyperkeratoses Suggests an Early Dysplastic Phenotype.

    Stojanov IJ, Woo SB

    Head and neck pathology 2022; (16(2)):366-374 doi:10.1007/s12105-021-01363-z.

    PMID: 34255278
  2. 2

    Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

    Chaturvedi AK, Udaltsova N, Engels EA, et al.

    Journal of the National Cancer Institute 2020; (112(10)):1047-1054 doi:10.1093/jnci/djz238.

    PMID: 31860085
  3. 3

    Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia.

    Bukovszky B, Fodor J, Tóth E, et al.

    Journal of clinical medicine 2023; (12(13)) doi:10.3390/jcm12134255.

    PMID: 37445290
  4. 4

    When Clinical Suspicion Outweighs a Negative Biopsy: Early Tongue Squamous Cell Carcinoma Diagnosed After Persistent Oral Leukoplakia.

    Reboredo P, Nogueira P, Boer N, et al.

    Cureus 2026; (18(8)):e114040 doi:10.7759/cureus.114040.

    PMID: 42701507
  5. 5

    Changes in the lesion surface suggesting transformation of oral potentially malignant disorders to malignancy - a report of eight cases.

    Kim MJ, Kho HS

    BMC oral health 2023; (23(1)):268 doi:10.1186/s12903-023-02960-w.

    PMID: 37161457
  6. 6

    New insights into the genetic progression of cancer through longitudinal analysis of oral lesions.

    Wils LJ, Poell JB, Brink A, et al.

    The Journal of pathology 2025; (267(2)):155-167 doi:10.1002/path.6449.

    PMID: 40728388
  7. 7

    The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.

    Wils LJ, Poell JB, Peferoen LAN, et al.

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2023; (52(10)):930-938 doi:10.1111/jop.13483.

    PMID: 37749621
  8. 8

    Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.

    Wils LJ, Poell JB, Evren I, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020; (33(6)):1033-1040 doi:10.1038/s41379-019-0444-0.

    PMID: 31896811
  9. 9

    Prevalence of Carcinomatous Foci in Oral Leukoplakia: A Clinicopathologic Study of 546 Indian Samples.

    Gopinath D, Thannikunnath BV, Neermunda SF

    Journal of clinical and diagnostic research : JCDR 2016; (10(8)):ZC78-83 doi:10.7860/JCDR/2016/16815.8305.

    PMID: 27656569
  10. 10

    Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis.

    Paglioni MP, Khurram SA, Ruiz BII, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2022; (134(5)):573-587 doi:10.1016/j.oooo.2022.07.006.

    PMID: 36153299
  11. 11

    Long-term outcome of non-surgical treatment in patients with oral leukoplakia.

    Kuribayashi Y, Tsushima F, Morita KI, et al.

    Oral oncology 2015; (51(11)):1020-1025 doi:10.1016/j.oraloncology.2015.09.004.

    PMID: 26410021
  12. 12

    Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.

    Jäwert F, Pettersson H, Jagefeldt E, et al.

    International journal of oral and maxillofacial surgery 2021; (50(11)):1422-1428 doi:10.1016/j.ijom.2021.01.012.

    PMID: 33674140
  13. 13

    Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis.

    Pimenta-Barros LA, Ramos-García P, González-Moles MÁ, et al.

    Oral diseases 2025; (31(1)):69-80 doi:10.1111/odi.15140.

    PMID: 39314164
  14. 14

    Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.

    Sundberg J, Korytowska M, Holmberg E, et al.

    PloS one 2019; (14(12)):e0225682 doi:10.1371/journal.pone.0225682.

    PMID: 31810078
  15. 15

    Malignant Transformation in Oral Potentially Malignant Disorders.

    González-Moles MÁ, Ramos-García P, Warnakulasuriya S

    Oral diseases 2026; doi:10.1111/odi.70527.

    PMID: 42830481
  16. 16

    Malignant transformation of proliferative Verrucous Leukoplakia-systematic review & meta-analysis.

    Mohideen K, Ghosh S, Krithika C, et al.

    BMC oral health 2025; (25(1)):175 doi:10.1186/s12903-025-05565-7.

    PMID: 39893387

This page explains oral cancer risk after a leukoplakia biopsy shows no dysplasia for informational purposes only and does not constitute medical advice. Your oral surgeon or treating clinician should interpret your results and tailor follow-up to your lesion.